Disease overarching mechanisms that explain and predict outcome of patients with high cardiovascular risk: rationale and design of the Berlin Long-term Observation of Vascular Events (BeLOVE) study

1 Charité Universitätsmedizin, Berlin, Germany;

2 Charité Universitätsmedizin, Berlin, Germany & Berlin Institute of Health, Berlin, Germany;

3 Berlin Institute of Health, Berlin, Germany;

2 Charité Universitätsmedizin, Berlin, Germany & Berlin Institute of Health, Berlin, Germany;

2 Charité Universitätsmedizin, Berlin, Germany & Berlin Institute of Health, Berlin, Germany;

4 Charité Universitätsmedizin, Berlin, Germany & Berlin Institute of Health, Berlin, Germany & German Centre for Cardiovascular Research (DZHK), partner site Berlin;

5 Berlin Institute of Health (BIH), Berlin, Germany & German Centre for Cardiovascular Research (DZHK), partner site Berlin & , Max-Delbräck Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany;

6 Berlin Institute of Health (BIH), Berlin, Germany;

7 Charité Universitätsmedizin, Berlin, Germany & Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany & German Centre for Cardiovascular Research (DZHK), partner site Berlin & Berlin Institute of H;

8 Berlin Institute of Health (BIH), Berlin, Germany & German Centre for Cardiovascular Research (DZHK), partner site Berlin & Charité Universitätsmedizin, Berlin, Germany;

1 Charité Universitätsmedizin, Berlin, Germany;

9 Charité Universitätsmedizin, Berlin, Germany & Berlin Institute of Health, Berlin, Germany & Charité-Center for Cardiovascular Research (CCR), Berlin, Germany;

10 Berlin Institute of Health (BIH), Berlin, Germany & German Centre for Cardiovascular Research (DZHK), partner site Berlin & Experimental and Clinical Research Center (ECRC), Berlin Germany & Max Delbruck Center for Molecular Medicine in the Helmholtz Asso;

11 Berlin Institute of Health (BIH), Berlin, Germany & Charité Universitätsmedizin, Berlin, Germany & German Centre for Cardiovascular Research (DZHK), partner site Berlin;

12 Berlin Institute of Health (BIH), Berlin, Germany & Charité Universitätsmedizin, Berlin, Germany;

13 Charité Universitätsmedizin, Berlin, Germany & Berlin Institute of Health, Berlin, Germany;

14 Charité Universitätsmedizin, Berlin, Germany & Max Delbruck Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany;

15 German Centre for Cardiovascular Research (DZHK), partner site Berlin & Charité Universitätsmedizin, Berlin, Germany;

16 Berlin Institute of Health (BIH), Berlin, Germany & German Centre for Cardiovascular Research (DZHK), partner site Berlin & Charité-Center for Cardiovascular Research (CCR), Berlin, Germany & Charité Universitätsmedizin, Berlin, Germany;

17 Berlin Institute of Health (BIH), Berlin, Germany & German Centre for Cardiovascular Research (DZHK), partner site Berlin & Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany & Charité Universitä